EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

There are still too few large-scale comparative studies. For future trials, we recommend to assess comorbidities, quality of life, symptoms and signs with standardized tools and attempt to better define responder profiles to specific drug treatments.